Kinase and receptor antibodies are bought to measure activity, and activity is a modification rather than an amount, so the reagent set is a phospho-specific clone against a named residue plus a total antibody, and the experiment is a stimulated sample beside an unstimulated one. Everything else on these datasheets is secondary to whether those two things exist.
An fgfr4 antibody and a pdgfra antibody on growth factor receptors
Receptor tyrosine kinase antibodies have to state which family member they see, because the kinase domains are similar and a clone raised against a conserved region reports the family rather than the receptor. Glycosylation on the extracellular part gives a broad band and moves the apparent mass, so a clean single band is not the expectation. For a phospho readout the stimulation has to be real, a ligand at a documented concentration and a short time course, since basal phosphorylation in a serum-fed culture hides the effect.
An osmr antibody and a tnfr1 antibody on cytokine receptors
Cytokine receptors are expressed at low copy number and signal as complexes, so a blot reports a faint band and immunoprecipitation is often the honest route. Both of these shed or are cleaved, which means a soluble form circulates and appears in conditioned medium, and a fall in surface staining can be release rather than loss. Where the receptor's function is the question, a neutralising clone specified by the concentration that blocks a stated bioassay is a different product from the staining reagent.
An s1pr2 antibody and a piezo1 antibody on membrane receptors and channels
A lipid receptor and a mechanosensitive channel are both multipass membrane proteins, which means the usual problems: aggregation on boiling, smeared glycosylated bands, and epitopes buried in lipid. The field's experience with G protein coupled receptor antibodies applies here, so genetic material is the control and a tagged construct is more trustworthy than most catalogue clones. For the channel, function is measured by patch clamp or calcium imaging, and the antibody supports localisation rather than carrying the claim.
A pkr antibody and a dmpk antibody on stress and disease kinases
The interferon-induced kinase is autophosphorylated on activation, so its useful reagent is the phospho clone with a stimulated control, typically double stranded RNA or an interferon treatment at a documented time. The myotonic dystrophy kinase is read in muscle and in disease models where the interest is expression level and isoform, and the repeat expansion that causes the disease is in the transcript rather than the protein, so an RNA readout carries part of the story that no antibody can.
Phospho clones, and the controls they oblige
A phospho-specific antibody is only as good as its controls: a stimulated positive sample, an unstimulated one, and ideally a phosphatase-treated lysate that should lose the signal. The lysis buffer carries phosphatase and kinase inhibitors from the first second, the sample is kept cold and not left in the freezer door, and the total protein is run on the same membrane so the ratio rather than the band is reported. A phospho blot with none of that is a picture rather than a measurement.
Inhibitor experiments and what the antibody has to show
Where a kinase inhibitor is the treatment, the antibody set has to demonstrate the pathway rather than the compound: the direct substrate's phosphorylation falls, a downstream node follows, and an unrelated pathway does not. Dose and time both belong on the figure, since a single high dose at one hour proves less than a short series. For targets with approved inhibitors, catalogues carry clones validated in that exact experiment, and the datasheet's own blot is worth reading before the order.
Immunoprecipitation for a receptor complex
Receptors signal in complexes, so the interesting experiment is often a pull down rather than a blot, and that changes the reagent requirement: a clone qualified for immunoprecipitation, a lysis buffer gentle enough to keep the complex together, and a control immunoprecipitation with an isotype-matched antibody. Crosslinking before lysis preserves transient associations at the cost of harsher elution. Where the partner is the question, reciprocal pull downs in both directions are what makes the result survive review.
What to ask for before ordering
Three things: the immunogen's position, which predicts whether an isoform or a cleaved form is seen; genetic validation in the application you will run; and the exact stimulation used in the datasheet's own figure, so the positive control can be reproduced on day one. For phospho clones add the residue and the surrounding sequence, because two suppliers' clones against the same site can differ in cross reactivity with a related kinase's identical motif.
Questions people ask about btk antibody
What makes a phospho blot a measurement?
A stimulated and an unstimulated sample, inhibitors in the lysis buffer, the total protein on the same membrane, and the ratio reported rather than the band.
Why does a receptor antibody give a broad band?
Glycosylation on the extracellular part, which spreads the band and moves the apparent mass. A single sharp band is not the expectation.
Are membrane receptor antibodies trustworthy?
Only with genetic controls. Where none exist, a tagged construct or a functional measurement carries the claim instead.